|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred costs | |||||
| Deferred income taxes | |||||
| Accretion of interest on convertible senior notes | |||||
| (Gain) loss on disposal of assets | |||||
| (Gain) loss on extinguishment of debt, capped call modification and change in fair value | |||||
| Provision for credit losses and sales reserve | |||||
| Stock-based compensation | |||||
| Change in fair value of contingent consideration obligation | |||||
| Payment of contingent consideration in excess of acquisition date fair value | |||||
| Other non-cash adjustments | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Deferred costs | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued payroll and employee related liabilities | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from landlord reimbursement | |||||
| Proceeds from sale of assets | |||||
| Payments for acquisition of business, net of acquired cash | |||||
| Additions to capitalized software development costs | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of convertible notes | |||||
| Payments of debt issuance costs | |||||
| Purchase of convertible notes capped call hedge | |||||
| Repurchase of convertible notes | |||||
| Proceeds from termination of convertible notes capped call hedge | |||||
| Payments of contingent consideration obligation | |||||
| Payments associated with shares withheld to settle employee tax withholding liability | |||||
| Proceeds from employee stock purchase plan | |||||
| Proceeds from option exercises | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rates on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash—beginning of year | |||||
| Cash, cash equivalents and restricted cash—end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest | |||||
| Taxes, net of refunds received | |||||
| Supplemental disclosure of non-cash activities | |||||
| Common stock issued in connection with acquisitions | |||||
| Contingent consideration in connection with acquisitions | |||||
| Common stock issued in connection with contingent consideration payment | |||||
| Purchase accounting payable, net | |||||
| Common stock issued in connection with settlement of convertible notes | |||||
| Modification of 2022 Notes capped call options and resulting reclassification from equity to derivative asset | |||||
| Common stock received in connection with settlement of capped call options | |||||
| Purchased intangible asset decrease | |||||
| Capitalized assets included in accounts payable and accrued expenses | |||||
| Capitalized development costs included in accounts payable and accrued expenses | |||||
| Stock-based compensation capitalized for software development | |||||
| Treasury stock retired | |||||
| Other non-cash activities | |||||
Loading...